Sevoflurane (n = 69) | Propofol and sevoflurane (n = 29) | Propofol (n = 85) | P value | |
---|---|---|---|---|
Donor | ||||
Age (years) | 34.3 [29.4–39.0] | 33.0 [30.2–36.8] | 33.8 [27.7–36.4] | .19 |
Sex | .94 | |||
Female | 31 (44.9) | 14 (48.3) | 40 (47.1) | |
Male | 38 (55.1) | 15 (51.7) | 45 (52.9) | |
Recipient | ||||
Age (years) | 1.3 [0.8–2.4] | 2.3 [0.9–4.3] | 1.5 [0.9–2.7] | .13 |
Sex | .94 | |||
Female | 40 (58.0) | 16 (55.2) | 47 (55.3) | |
Male | 29 (42.0) | 13 (44.8) | 38 (44.7) | |
Weight (kg) | 9.4 [7.7–12.4] | 12.0 [8.7–15.9] | 9.1 [7.4–14.0] | .15 |
Liver pathology | .10 | |||
Biliary atresia | 51 (73.9) | 16 (55.2) | 51 (60.0) | |
Other | 18 (26.1) | 13 (44.8) | 18 (40.0) | |
Cirrhosis | 59 (85.5) | 26 (89.7) | 72 (84.7) | .80 |
ASAT (U/L) | 167 [92–226] | 171 [87–249] | 144 [82–229] | .97 |
ALAT (U/L) | 82 [47–124] | 119 [38–148] | 87 [49–128] | .61 |
Bilirubin (mg/dL) | 16.1 [2.7–21.5] | 13.5 [2.9–22.4] | 14.2 [2.9–19.7] | .76 |
INR | 1.28 [1.11–1.67] | 1.19 [1.03–1.57] | 1.31 [1.08–1.58] | .38 |
Urea (mg/dL) | 15 [11–19] | 17 [13–26] | 17 [14–22] | .14 |
Creatinin (mg/dL) | 0.24 [0.19–0.31] | 0.32 [0.19–0.39] | 0.24 [0.19–0.34] | .16 |
Albumin (g/L) | 33 [29–38] | 34 [31–41] | 32 [28–37] | .27 |
NLR | 0.9 [0.7–1.6] | 1.1 [0.6–1.4] | 1.1 [0.6–1.7] | .51 |